Entry of Epidemic Keratoconjunctivitis-Associated Human Adenovirus Type 37 in Human Corneal Epithelial Cells.
Adenovirus Infections, Human
/ virology
Adenoviruses, Human
/ physiology
Animals
Cell Line
Clathrin-Coated Vesicles
/ virology
Dynamin II
/ metabolism
Epithelium, Corneal
/ ultrastructure
Humans
Hydrogen-Ion Concentration
Keratoconjunctivitis, Infectious
/ virology
Lysosomal Membrane Proteins
/ metabolism
Microscopy, Confocal
Microscopy, Electron, Transmission
Pinocytosis
Real-Time Polymerase Chain Reaction
Virus Internalization
p21-Activated Kinases
/ metabolism
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
03 08 2020
03 08 2020
Historique:
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
7
1
2021
Statut:
ppublish
Résumé
Ocular infection by human adenovirus species D type 37 (HAdV-D37) causes epidemic keratoconjunctivitis, a severe, hyperacute condition. The corneal component of epidemic keratoconjunctivitis begins upon infection of corneal epithelium, and the mechanism of viral entry dictates subsequent proinflammatory gene expression. Therefore, it is important to understand the specific pathways of adenoviral entry in these cells. Transmission electron microscopy of primary and tert-immortalized human corneal epithelial cells infected with HAdV-D37 was performed to identify the means of viral entry. Confocal microscopy was used to determine intracellular trafficking. The results of targeted small interfering RNA and specific chemical inhibitors were analyzed by quantitative PCR, and Western blot. By transmission electron microscopy, HAdV-D37 was seen to enter by both clathrin-coated pits and macropinocytosis; however, entry was both pH and dynamin 2 independent. Small interfering RNA against clathrin, AP2A1, and lysosome-associated membrane protein 1, but not early endosome antigen 1, decreased early viral gene expression. Ethyl-isopropyl amiloride, which blocks micropinocytosis, did not affect HAdV-D37 entry, but IPA, an inhibitor of p21-activated kinase, and important to actin polymerization, decreased viral entry in a dose-dependent manner. HAdV-D37 enters human corneal epithelial cells by a noncanonical clathrin-mediated pathway involving lysosome-associated membrane protein 1 and PAK1, independent of pH, dynamin, and early endosome antigen 1. We showed earlier that HAdV-D37 enters human keratocytes through caveolae. Therefore, epidemic keratoconjunctivitis-associated viruses enter different corneal cell types via disparate pathways, which could account for a relative paucity of proinflammatory gene expression upon infection of corneal epithelial cells compared with keratocytes, as seen in prior studies.
Identifiants
pubmed: 32852546
pii: 2770720
doi: 10.1167/iovs.61.10.50
pmc: PMC7453050
doi:
Substances chimiques
Lysosomal Membrane Proteins
0
PAK1 protein, human
EC 2.7.11.1
p21-Activated Kinases
EC 2.7.11.1
Dynamin II
EC 3.6.5.5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Subventions
Organisme : NEI NIH HHS
ID : P30 EY014104
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY013124
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY021558
Pays : United States
Références
J Biol Chem. 2014 Jan 10;289(2):680-95
pubmed: 24273169
Nature. 1998 Jul 30;394(6692):494-8
pubmed: 9697774
Viruses. 2019 Apr 27;11(5):
pubmed: 31035532
Cell Death Differ. 2009 Jan;16(1):70-8
pubmed: 19008921
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11790-5
pubmed: 18689690
Curr Med Chem. 1999 Dec;6(12):1197-212
pubmed: 10519916
Surv Ophthalmol. 2015 Sep-Oct;60(5):435-43
pubmed: 26077630
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22260-5
pubmed: 21135248
Sci STKE. 2002 Jul 16;2002(141):pe32
pubmed: 12122203
Hum Gene Ther. 1998 Feb 10;9(3):367-78
pubmed: 9508054
Cell. 1983 Feb;32(2):607-17
pubmed: 6130853
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9559-E9568
pubmed: 29078380
Sci Rep. 2013;3:1812
pubmed: 23657240
Nat Rev Mol Cell Biol. 2007 Nov;8(11):917-29
pubmed: 17912264
J Virol. 1994 Jun;68(6):3713-23
pubmed: 8189509
Cell. 1993 Apr 23;73(2):309-19
pubmed: 8477447
Nat Rev Mol Cell Biol. 2011 Nov 23;13(1):53-60
pubmed: 22108513
PLoS Pathog. 2018 Mar 9;14(3):e1006914
pubmed: 29522575
Annu Rev Biochem. 2010;79:803-33
pubmed: 20196649
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3820-5
pubmed: 22343291
Org Biomol Chem. 2015 Sep 21;13(35):9194-205
pubmed: 26177934
J Virol. 1998 Oct;72(10):7909-15
pubmed: 9733828
J Virol. 1993 Aug;67(8):4777-84
pubmed: 7687302
Annu Rev Biochem. 2009;78:857-902
pubmed: 19317650
J Cell Biol. 2009 Jun 15;185(6):939-48
pubmed: 19528294
J Virol. 2014 Sep;88(18):10354-63
pubmed: 24991003
Mol Biol Cell. 2000 Oct;11(10):3341-52
pubmed: 11029040
Epidemiol Rev. 1987;9:244-61
pubmed: 2824228
J Virol. 1994 Oct;68(10):6811-4
pubmed: 8084019
Cell Microbiol. 2013 Jan;15(1):53-62
pubmed: 23083122
EMBO J. 2001 Mar 15;20(6):1310-9
pubmed: 11250897
J Virol. 2013 Nov;87(22):12367-79
pubmed: 24027314
J Cell Biol. 1999 May 17;145(4):837-49
pubmed: 10330410
PLoS One. 2011;6(10):e25464
pubmed: 22022400
J Med Virol. 1981;7(2):105-18
pubmed: 7264611
Viruses. 2019 Mar 12;11(3):
pubmed: 30870979
PLoS Biol. 2009 Mar 17;7(3):e57
pubmed: 19296720
Biochem Soc Trans. 2009 Oct;37(Pt 5):1022-6
pubmed: 19754444
Viruses. 2015 Dec 07;7(12):6387-99
pubmed: 26690201
J Cell Sci. 2006 Oct 15;119(Pt 20):4235-46
pubmed: 16984970
Mol Cell Biol. 2006 Jan;26(2):389-401
pubmed: 16382132
Annu Rev Virol. 2019 Sep 29;6(1):177-197
pubmed: 31283442
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
J Cell Sci. 2017 Aug 15;130(16):2682-2695
pubmed: 28655854
J Cell Biol. 2002 Sep 16;158(6):1119-31
pubmed: 12221069
J Virol. 2010 May;84(10):5336-50
pubmed: 20237079
PLoS Pathog. 2011 Mar;7(3):e1001329
pubmed: 21483486
J Cell Biol. 2003 Sep 1;162(5):909-18
pubmed: 12952941
PLoS One. 2013 Sep 03;8(9):e73063
pubmed: 24019894
FEBS Lett. 2018 Nov;592(22):3658-3669
pubmed: 29935019
Viruses. 2019 Mar 12;11(3):
pubmed: 30871026
Virology. 2019 Mar;529:43-56
pubmed: 30660774
J Cell Biol. 2006 Jul 31;174(3):459-71
pubmed: 16880274
J Cell Biol. 1987 Oct;105(4):1473-8
pubmed: 3312229
Microorganisms. 2019 Sep 13;7(9):
pubmed: 31540200
J Virol. 1997 Jan;71(1):398-404
pubmed: 8985363
J Virol. 2015 Jul;89(13):6673-84
pubmed: 25878109
J Virol. 2007 Feb;81(3):1305-12
pubmed: 17108047
J Virol. 2019 Jul 30;93(16):
pubmed: 31142668
Annu Rev Biochem. 2012;81:661-86
pubmed: 22663081
EMBO J. 2008 Apr 9;27(7):956-69
pubmed: 18323776
Trends Cell Biol. 1995 Nov;5(11):424-8
pubmed: 14732047
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2804-11
pubmed: 22467570
Virology. 1970 Mar;40(3):462-77
pubmed: 5437781
Traffic. 2008 Dec;9(12):2265-78
pubmed: 18980614
Nat Med. 2011 Jan;17(1):105-9
pubmed: 21151139
Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17
pubmed: 11252952
Mol Biol Cell. 2017 Oct 15;28(21):2802-2818
pubmed: 28814502
Nat Rev Microbiol. 2011 Jun;9(6):427-39
pubmed: 21522191
FASEB J. 1999 Dec;13 Suppl 2:S243-7
pubmed: 10619136
PLoS One. 2013 Oct 11;8(10):e77462
pubmed: 24147000
Trends Cell Biol. 2006 Oct;16(10):505-13
pubmed: 16935508
J Biol Chem. 2004 Apr 16;279(16):16657-61
pubmed: 14985334
J Biol Chem. 2011 Jan 7;286(1):309-21
pubmed: 20956521
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):470-8
pubmed: 15671271
J Virol. 2006 Dec;80(23):11833-51
pubmed: 16987972
Viruses. 2011 Aug;3(8):1417-31
pubmed: 21994788
BMC Genomics. 2008 May 09;9:213
pubmed: 18471294
EMBO J. 1998 Nov 16;17(22):6527-40
pubmed: 9822598